Effets des Amendements Organiques sur la Gale Bactérienne et la Pourriture Apicale de la Tomate à Bobo-Dioulasso au Burkina Faso

L’étude a porté sur les effets des amendements organiques sur la gale bactérienne et la pourriture apicale de la tomate en milieu réel à l’Ouest du Burkina Faso. Un essai a été mis en place dans un dispositif en bloc de Fisher complètement randomisé. Il a comporté huit (08) traitements constitués des fertilisants organiques et minéraux tous répétés quatre (04) fois. L’incidence de la maladie et sa sévérité ont été évaluées ainsi que l’effet des traitements sur la qualité des fruits. La progression est relativement faible avec les déchets ménagers compostés associés aux engrais minéraux. La maladie est plus sévère avec les différents fertilisants pris individuellement. Dans l’ensemble, la maladie est évolutive avec tous les traitements.   The study focused on the effects of organic amendments on bacterial scab and apical rot of tomato in a real environment in western Burkina Faso. Indeed, a trial was set up in a completely randomized Fisher block design. It included eight (08) treatments consisting of organic and mineral fertilizers all repeated four (04) times. The incidence of the disease and its severity were evaluated as well as the effect of the treatments on the quality of the fruits. The disease is progressive with all treatments. However, the progression is relatively low with composted household waste associated with mineral fertilizers. The disease is more severe with the different fertilizers taken individually

Epithelial maturation and molecular biology of oral HPV

Human papillomavirus (HPV) is widespread and can cause latent infection in basal cells, with low HPV DNA copy-number insufficient for transmission of infection; can cause subclinical infection that is active but without clinical signs; or can cause clinical infection leading to benign, potentially malignant or malignant lesions. The HPV cycle is influenced by the stage of maturation of the infected keratinocytes, and the production of virions is restricted to the post-mitotic suprabasal epithelial cells where all the virus genes are expressed

Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries

BACKGROUND: The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact on clinical presentation in a large sample of patients with retinoblastoma from Africa and Europe. METHODS: A cross-sectional analysis including 518 treatment-naïve patients with retinoblastoma residing in 40 European countries and 1024 treatment-naïve patients with retinoblastoma residing in 43 African countries. RESULTS: Capture rate was 42.2% of expected patients from Africa and 108.8% from Europe. African patients were older (95% CI -12.4 to -5.4, p<0.001), had fewer cases of familial retinoblastoma (95% CI 2.0 to 5.3, p<0.001) and presented with more advanced disease (95% CI 6.0 to 9.8, p<0.001); 43.4% and 15.4% of Africans had extraocular retinoblastoma and distant metastasis at the time of diagnosis, respectively, compared to 2.9% and 1.0% of the Europeans. To reach a retinoblastoma centre, European patients travelled 421.8 km compared to Africans who travelled 185.7 km (p<0.001). On regression analysis, lower-national income level, African residence and older age (p<0.001), but not travel distance (p=0.19), were risk factors for advanced disease. CONCLUSIONS: Fewer than half the expected number of patients with retinoblastoma presented to African referral centres in 2017, suggesting poor awareness or other barriers to access. Despite the relatively shorter distance travelled by African patients, they presented with later-stage disease. Health education about retinoblastoma is needed for carers and health workers in Africa in order to increase capture rate and promote early referral

Global Retinoblastoma Presentation and Analysis by National Income Level

Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n = 3685 [84.7%]) were from low- A nd middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 [62.8%]), followed by strabismus (n = 429 [10.2%]) and proptosis (n = 309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs

Global Retinoblastoma Presentation and Analysis by National Income Level

Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4) were female. Most patients (n = 3685 84.7%) were from low-and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 62.8%), followed by strabismus (n = 429 10.2%) and proptosis (n = 309 7.4%). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 95% CI, 12.94-24.80, and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 95% CI, 4.30-7.68). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs. © 2020 American Medical Association. All rights reserved

Imunohistochemické a vybrané genetické reflexní testy pro všechny děložní leiomyosarkomy a STUMP pro genové přeskupení ALK mohou poskytovat účinný screeningový nástroj pro identifikaci mezenchymálních nádorů s přeskupeným ALK

Zkoumali jsme hodnotu cíleného molekulárního screeningu pro identifikaci mezenchymálních nádorů s přesmykem děložního anaplastického lymfomu (ALK), včetně imunohistochemie ALK následované molekulárně genetickým testováním, u všech děložních leiomyosarkomů a STUMP (nádory hladkého svalstva s nejistým maligním potenciálem). Všechny případy leiomyosarkomu a STUMP diagnostikované v 10letém období (2006–2016) na LF UK v Plzni byly získány a přezkoumány. Z 23 případů byl jeden případ (LMS [leiomyosarkom]) pozitivní na přeskupení ALK, a to fúzní gen PPP1CB – ALK. V tomto případě nebyly pozorovány žádné specifické histologické znaky (tj. Lymfocytární infiltrát a stromální edém). To naznačuje, že histologické rysy podobné zánětlivým myofibroblastickým nádorům (IMT) nemusí být počátečním spolehlivým screeningovým nástrojem při identifikaci děložních IMT případů. Navrhli jsme tedy dvoustupňové IHC a molekulární genetické testování (jako reflexní test) na IMT ve všech případech LMS a STUMP dělohy. To zlepší správnou detekci nádorů tohoto typu v populaci a tím se vytvoří možnost pro dostupnou a cílenou terapii.In a recent paper in Electron. J. Combin. 23 (2016) Estélyi and Pisanski raised a question whether there exist vertex-transitive Haar graphs that are not Cayley graphs. In this note we construct an infinite family of trivalent Haar graphs that are vertex-transitive but non-Cayley. The smallest example has 40 vertices and is the well-known Kronecker cover over the dodecahedron graph G(10,2), occurring as the graph ‘40’ in the Foster census of connected symmetric trivalent graphs